浙江新冠病毒抗体检测定价40元,发热门诊患者可医保报销

2020-05-07 陆玫 澎湃新闻

浙江省医疗保障局、省卫健委5月6日发布《关于明确新型冠状病毒抗体检测项目有关事项的通知》,决定设立新型冠状病毒IgG抗体(包括总抗体)检测和IgM抗体检测项目,试行价格均为40元/次;其医保支付类别按

浙江省医疗保障局、省卫健委5月6日发布《关于明确新型冠状病毒抗体检测项目有关事项的通知》,决定设立新型冠状病毒IgG抗体(包括总抗体)检测和IgM抗体检测项目,试行价格均为40元/次;其医保支付类别按甲类管理,医保支付范围限发热门诊或有新冠肺炎影像学特征的患者。

澎湃新闻 了解到,血清抗体检测是对核酸检测的有效补充,通过检测人体对病毒的免疫反应获得结果。如近期有新冠病毒感染,人体会产生抗体(包括lgM、lgG)。研究发现,lgM抗体一般在7天后产生,lgG抗体一般在10天后产生。抗体检测操作方便,结果等待时间短,可作为病毒核酸检测阴性疑似病例的补充检测指标或疑似病例中与核酸检测协同使用,以及对既往感染者和无症状感染者的初步筛查。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
    2021-01-16 丁鹏鹏
  2. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
    2020-05-09 marongnuan
  7. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1662324, encodeId=83e3166232416, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Sat Jan 16 15:21:23 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Mon May 11 15:21:23 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647537, encodeId=a989164e53762, content=<a href='/topic/show?id=38043385561' target=_blank style='color:#2F92EE;'>#医保报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33855, encryptionId=38043385561, topicName=医保报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a3823444828, createdName=guguangxiang, createdTime=Mon Aug 17 17:21:23 CST 2020, time=2020-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005028, encodeId=dec5200502854, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Tue Nov 24 00:21:23 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932050, encodeId=deb61932050e4, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Wed Jun 17 08:21:23 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305218, encodeId=e6d9130521839, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469635, encodeId=644c146963519, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535794, encodeId=5a101535e94e1, content=<a href='/topic/show?id=0e8a551866c' target=_blank style='color:#2F92EE;'>#抗体检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55186, encryptionId=0e8a551866c, topicName=抗体检测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=682812619358, createdName=tongyongming, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545781, encodeId=c4621545e8128, content=<a href='/topic/show?id=8df5560640e' target=_blank style='color:#2F92EE;'>#报销#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56064, encryptionId=8df5560640e, topicName=报销)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 09 13:21:23 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027972, encodeId=a552102e9726a, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri May 08 01:21:23 CST 2020, time=2020-05-08, status=1, ipAttribution=)]
    2020-05-08 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

浙江城乡居民基本养老保险有新政策!明年起这些变化影响你我

近日,经浙江省委、省政府同意,省人力社保厅会同省财政厅印发《关于建立城乡居民基本养老保险待遇确定和基础养老金正常调整机制的实施意见》,对完善待遇确定机制、建立基础养老金正常调整机制、调整个人缴费档次等事项进行了明确。《实施意见》自2020年1月1日起实施。《实施意见》要求各地各有关部门切实把政策落实到位,随小布详细了解~完善待遇确定机制浙江城乡居民基本养老保险待遇由基础养老金、个人账户养老金和缴费

BMJ:中国浙江省SARS-Cov-2感染者的临床特征

截至2020年2月上旬,与武汉市感染SARS-Cov-2的患者相比,浙江省感染患者的症状较轻。

取消GMP/GSP认证,这个省执行了

取消GMP、GSP认证,正式打响第一枪。

浙江出院患者占确诊病例94.9%,重点防控境外疫情输入

3月6日从浙江省新冠肺炎疫情防控工作新闻发布会获悉,截至3月5日24时,浙江累计报告新冠肺炎确诊病例1215例(其中境外输入病例10例),现有重症病例2例(其中危重1例),累计死亡1例,累计出院115

浙江分级诊疗新探索让基层儿科医生强起来

“前几年,浙江儿科医生流失率超过30%,近几年稳定在20%左右。”在近日举行的浙江省儿童疾病分级诊疗项目年度总结报告会上,浙江省卫生健康委相关负责人说,浙江通过分级诊疗与培养基层儿科人才相结合的创新探索,逐步破解儿科医疗资源总量不足、优质资源短缺、分布不均衡和结构不合理等问题。2019年度,浙江大学医学院附属儿童医院(以下简称“浙大儿院”)分别在浙江温州、义乌等五地开展了多场分级诊疗基层儿科医生培

浙江共发现20例复阳病例:未分离到活病毒、未再感染他人

4月3日,澎湃新闻从浙江省新型冠状病毒肺炎疫情防控工作新闻发布会获悉,目前浙江共发现20例“复阳”病例。